Thanks to groundbreaking advancements in precision medicine and immunotherapy, the biotech industry is undergoing a transformative phase, particularly in cancer treatment. The companies are reshaping the way cancer is diagnosed and treated with innovations.
Below, I have highlighted three fundamentally strong biotech stocks: Regeneron Pharmaceuticals, Inc. (REGN), Amgen Inc. (AMGN), and Gilead Sciences, Inc. (GILD), which are well-positioned for long-term growth with their research breakthroughs.
